Detalhe da pesquisa
1.
Targeting N-cadherin increases vascular permeability and differentially activates AKT in melanoma.
Ann Surg
; 261(2): 368-77, 2015 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-24646553
2.
Clinical, molecular, metabolic, and immune features associated with oxidative phosphorylation in melanoma brain metastases.
Neurooncol Adv
; 3(1): vdaa177, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33575655
3.
Fever-range whole body thermotherapy combined with oxaliplatin: a curative regimen in a pre-clinical breast cancer model.
Int J Hyperthermia
; 26(6): 565-76, 2010.
Artigo
em Inglês
| MEDLINE | ID: mdl-20707651
4.
A Novel Mitochondrial Inhibitor Blocks MAPK Pathway and Overcomes MAPK Inhibitor Resistance in Melanoma.
Clin Cancer Res
; 25(21): 6429-6442, 2019 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31439581
5.
Molecular Profiling Reveals Unique Immune and Metabolic Features of Melanoma Brain Metastases.
Cancer Discov
; 9(5): 628-645, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30787016
6.
ALK Fusion Partners Impact Response to ALK Inhibition: Differential Effects on Sensitivity, Cellular Phenotypes, and Biochemical Properties.
Mol Cancer Res
; 16(11): 1724-1736, 2018 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30002191
7.
A Multicenter Phase I Study Evaluating Dual PI3K and BRAF Inhibition with PX-866 and Vemurafenib in Patients with Advanced BRAF V600-Mutant Solid Tumors.
Clin Cancer Res
; 24(1): 22-32, 2018 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29051322
8.
Characterization of Human Cancer Cell Lines by Reverse-phase Protein Arrays.
Cancer Cell
; 31(2): 225-239, 2017 02 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-28196595
9.
Estrogen-mediated down-regulation of E-cadherin in breast cancer cells.
Cancer Res
; 63(17): 5203-8, 2003 Sep 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-14500345
10.
RMEL3, a novel BRAFV600E-associated long noncoding RNA, is required for MAPK and PI3K signaling in melanoma.
Oncotarget
; 7(24): 36711-36718, 2016 Jun 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-27167340
11.
Loss of PTEN Promotes Resistance to T Cell-Mediated Immunotherapy.
Cancer Discov
; 6(2): 202-16, 2016 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-26645196
12.
Insulin-like growth factor-I inhibits progesterone receptor expression in breast cancer cells via the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin pathway: progesterone receptor as a potential indicator of growth factor activity in breast cancer.
Mol Endocrinol
; 17(4): 575-88, 2003 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-12554765
13.
BRAFV600E Co-opts a Conserved MHC Class I Internalization Pathway to Diminish Antigen Presentation and CD8+ T-cell Recognition of Melanoma.
Cancer Immunol Res
; 3(6): 602-9, 2015 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-25795007
14.
Inhibition of mTORC1/2 overcomes resistance to MAPK pathway inhibitors mediated by PGC1α and oxidative phosphorylation in melanoma.
Cancer Res
; 74(23): 7037-47, 2014 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-25297634
15.
Molecular profiling of patient-matched brain and extracranial melanoma metastases implicates the PI3K pathway as a therapeutic target.
Clin Cancer Res
; 20(21): 5537-46, 2014 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-24803579
16.
Phase I study of the combination of sorafenib and temsirolimus in patients with metastatic melanoma.
Clin Cancer Res
; 18(4): 1120-8, 2012 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-22223528
17.
Basal and treatment-induced activation of AKT mediates resistance to cell death by AZD6244 (ARRY-142886) in Braf-mutant human cutaneous melanoma cells.
Cancer Res
; 70(21): 8736-47, 2010 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-20959481
18.
Integrative analysis of proteomic signatures, mutations, and drug responsiveness in the NCI 60 cancer cell line set.
Mol Cancer Ther
; 9(2): 257-67, 2010 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-20124458
19.
Integrated Molecular and Clinical Analysis of AKT Activation in Metastatic Melanoma.
Clin Cancer Res
; 15(24): 7538-7546, 2009 Dec 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-19996208
20.
SAFB2, a new scaffold attachment factor homolog and estrogen receptor corepressor.
J Biol Chem
; 278(22): 20059-68, 2003 May 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-12660241